Australia markets open in 4 hours 12 minutes

iBio, Inc. (IBIO)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
2.1410-0.1390 (-6.10%)
As of 03:45PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 19.66M
Enterprise value 31.69M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)86.64
Price/book (mrq)0.79
Enterprise value/revenue 633.88
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -3.35
52-week change 3-82.46%
S&P500 52-week change 325.22%
52-week high 316.0000
52-week low 31.0200
50-day moving average 32.0950
200-day moving average 32.9887

Share statistics

Avg vol (3-month) 33.95M
Avg vol (10-day) 3137.22k
Shares outstanding 58.62M
Implied shares outstanding 68.62M
Float 86.62M
% held by insiders 10.18%
% held by institutions 135.29%
Shares short (15 May 2024) 480.57k
Short ratio (15 May 2024) 40.5
Short % of float (15 May 2024) 40.94%
Short % of shares outstanding (15 May 2024) 40.93%
Shares short (prior month 15 Apr 2024) 4184.45k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 June 2018
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 329 Nov 2023

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)-36,380.00%

Management effectiveness

Return on assets (ttm)-24.05%
Return on equity (ttm)-81.08%

Income statement

Revenue (ttm)50k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -17.25M
Net income avi to common (ttm)-17.13M
Diluted EPS (ttm)-7.2300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.3M
Total cash per share (mrq)0.62
Total debt (mrq)17.96M
Total debt/equity (mrq)72.22%
Current ratio (mrq)1.69
Book value per share (mrq)2.92

Cash flow statement

Operating cash flow (ttm)-18.67M
Levered free cash flow (ttm)-16.6M